Regarding the wider risk predictors of Hb response to parenteral iron, Black ethnicity, lower BMI, diabetes, total iron dose above 20 mg/kg, higher baseline MCV, and presence of FID were independently associated with poor response (Figure 4). The gene discussed is GSTM1; the disease is diabetes mellitus.